# VASO Corp: filings

VASO · OTC · CIK 839087 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vaso.md) · [Financials](/companies/vaso/financials.md) · [Filings](/companies/vaso/filings.md) · [Insiders](/companies/vaso/insiders.md)

## Reports and events: 153 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 76, 10-Q 54, 8-K 49, 10-K 17, DEF 14A 15, UPLOAD 13, 3 12, 4/A 10, CORRESP 8, 10-K/A 7, 8-K/A 6, DEFA14A 6, 10-Q/A 3, 425 3, NT 10-K 3, NT 10-Q 2, PRE 14A 2, PRER14A 2, SCHEDULE 13D 2, 10-KT 1, 3/A 1, CT ORDER 1, PREM14A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 13:48 ET | [DEF 14A](/filings/0001213900-26-113710.md) | Proxy statement, period 2026-12-08 | 0001213900-26-113710 |
| 2026-08-14 | 16:02 ET | [10-Q](/filings/0001213900-26-090009.md) | Quarterly report, period 2026-06-30 | 0001213900-26-090009 |
| 2026-08-06 | 16:05 ET | [8-K/A](/filings/0001213900-26-086128.md) | 9.01 Financial statements and exhibits | 0001213900-26-086128 |
| 2026-07-31 | 17:01 ET | [8-K](/filings/0001213900-26-084076.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 9.01 Financial statements and exhibits | 0001213900-26-084076 |
| 2026-07-23 | 17:14 ET | [8-K](/filings/0001213900-26-080991.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-080991 |
| 2026-05-15 | 16:02 ET | [10-Q](/filings/0001213900-26-057690.md) | Quarterly report, period 2026-03-31 | 0001213900-26-057690 |
| 2026-05-08 | 16:01 ET | [8-K](/filings/0001213900-26-053854.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001213900-26-053854 |
| 2026-04-16 | 09:03 ET | [SCHEDULE 13D](/filings/0001213900-26-044358.md) | Ownership report, active investor | 0001213900-26-044358 |
| 2026-04-10 | 09:29 ET | [SCHEDULE 13D](/filings/0001213900-26-042214.md) | Ownership report, active investor | 0001213900-26-042214 |
| 2026-03-31 | 17:25 ET | [10-K](/filings/0001213900-26-037664.md) | Annual report, period 2025-12-31 | 0001213900-26-037664 |
| 2026-02-12 | 15:20 ET | [8-K](/filings/0001213900-26-015515.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-015515 |
| 2025-12-19 | 10:55 ET | [8-K](/filings/0001213900-25-123593.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-123593 |
| 2025-11-20 | 12:18 ET | [8-K](/filings/0001213900-25-112966.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-112966 |
| 2025-11-14 | 16:41 ET | [10-Q](/filings/0001213900-25-110955.md) | Quarterly report, period 2025-09-30 | 0001213900-25-110955 |
| 2025-11-05 | 06:10 ET | [DEF 14A](/filings/0001213900-25-106419.md) | Proxy statement, period 2025-12-17 | 0001213900-25-106419 |
| 2025-08-14 | 16:04 ET | [10-Q](/filings/0001213900-25-076616.md) | Quarterly report, period 2025-06-30 | 0001213900-25-076616 |
| 2025-05-15 | 16:14 ET | [10-Q](/filings/0001213900-25-044213.md) | Quarterly report, period 2025-03-31 | 0001213900-25-044213 |
| 2025-03-31 | 16:46 ET | [10-K](/filings/0001213900-25-026337.md) | Annual report, period 2024-12-31 | 0001213900-25-026337 |
| 2025-01-03 | 16:08 ET | [8-K](/filings/0001213900-25-000753.md) | 5.02 Departure or appointment of officers or directors | 0001213900-25-000753 |
| 2024-11-14 | 16:00 ET | [10-Q](/filings/0001213900-24-098378.md) | Quarterly report, period 2024-09-30 | 0001213900-24-098378 |
| 2024-09-19 | 18:31 ET | [8-K](/filings/0001213900-24-079992.md) | 1.02 Termination of a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-079992 |
| 2024-09-10 | 17:05 ET | [8-K](/filings/0001213900-24-077416.md) | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-077416 |
| 2024-08-28 | 17:33 ET | [8-K](/filings/0001213900-24-073043.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-073043 |
| 2024-08-23 | 16:01 ET | [8-K](/filings/0001213900-24-072203.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-24-072203 |
| 2024-08-14 | 16:00 ET | [10-Q](/filings/0001213900-24-068957.md) | Quarterly report, period 2024-06-30 | 0001213900-24-068957 |
| 2024-08-07 | 19:04 ET | [DEF 14A](/filings/0001213900-24-065802.md) | Proxy statement, period 2024-08-26 | 0001213900-24-065802 |
| 2024-05-15 | 16:01 ET | [10-Q](/filings/0001213900-24-043559.md) | Quarterly report, period 2024-03-31 | 0001213900-24-043559 |
| 2024-04-01 | 16:06 ET | [10-K](/filings/0001213900-24-028734.md) | Annual report, period 2023-12-31 | 0001213900-24-028734 |
| 2023-12-08 | 20:42 ET | [8-K](/filings/0001654954-23-015266.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001654954-23-015266 |
| 2023-11-14 | 16:07 ET | [10-Q](/filings/0001654954-23-014359.md) | Quarterly report, period 2023-09-30 | 0001654954-23-014359 |
| 2023-08-14 | 16:00 ET | [10-Q](/filings/0001654954-23-010753.md) | Quarterly report, period 2023-06-30 | 0001654954-23-010753 |
| 2023-05-15 | 16:18 ET | [10-Q](/filings/0001654954-23-006577.md) | Quarterly report, period 2023-03-31 | 0001654954-23-006577 |
| 2023-04-03 | 10:25 ET | [8-K](/filings/0001654954-23-004199.md) | 5.02 Departure or appointment of officers or directors | 0001654954-23-004199 |
| 2023-03-31 | 17:30 ET | [10-K](/filings/0001654954-23-004142.md) | Annual report, period 2022-12-31 | 0001654954-23-004142 |
| 2022-11-14 | 16:17 ET | [10-Q](/filings/0001654954-22-015274.md) | Quarterly report, period 2022-09-30 | 0001654954-22-015274 |
| 2022-10-03 | 16:03 ET | [DEF 14A](/filings/0001654954-22-013242.md) | Proxy statement, period 2022-11-15 | 0001654954-22-013242 |
| 2022-09-16 | 16:00 ET | [8-K](/filings/0001654954-22-012632.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001654954-22-012632 |
| 2022-08-15 | 16:25 ET | [10-Q](/filings/0001654954-22-011378.md) | Quarterly report, period 2022-06-30 | 0001654954-22-011378 |
| 2022-05-16 | 16:08 ET | [10-Q](/filings/0001654954-22-006968.md) | Quarterly report, period 2022-03-31 | 0001654954-22-006968 |
| 2022-03-31 | 16:08 ET | [10-K](/filings/0001654954-22-004333.md) | Annual report, period 2021-12-31 | 0001654954-22-004333 |
| 2021-11-15 | 16:07 ET | [10-Q](/filings/0001654954-21-012209.md) | Quarterly report, period 2021-09-30 | 0001654954-21-012209 |
| 2021-08-27 | 09:15 ET | [DEF 14A](/filings/0001654954-21-009494.md) | Proxy statement, period 2021-10-12 | 0001654954-21-009494 |
| 2021-08-16 | 16:52 ET | [10-Q](/filings/0001654954-21-009103.md) | Quarterly report, period 2021-06-30 | 0001654954-21-009103 |
| 2021-06-25 | 06:02 ET | [8-K](/filings/0001654954-21-007266.md) | 1.02 Termination of a material agreement | 0001654954-21-007266 |
| 2021-06-04 | 15:17 ET | [10-Q](/filings/0001654954-21-006610.md) | Quarterly report, period 2021-03-31 | 0001654954-21-006610 |
| 2021-05-05 | 17:34 ET | [10-K](/filings/0001654954-21-005117.md) | Annual report, period 2020-12-31 | 0001654954-21-005117 |
| 2020-11-13 | 16:06 ET | [10-Q](/filings/0001654954-20-012351.md) | Quarterly report, period 2020-09-30 | 0001654954-20-012351 |
| 2020-08-14 | 16:02 ET | [10-Q](/filings/0001654954-20-009163.md) | Quarterly report, period 2020-06-30 | 0001654954-20-009163 |
| 2020-06-04 | 16:01 ET | [10-Q](/filings/0001654954-20-006323.md) | Quarterly report, period 2020-03-31 | 0001654954-20-006323 |
| 2020-05-14 | 16:01 ET | [8-K](/filings/0001654954-20-005467.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001654954-20-005467 |

Page 1 of 4. [Older](/companies/vaso/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 13:52 ET. No prices; not investment advice.